title: Spheronization of solid lipid extrudates: A novel approach on controlling critical process parameters.
abstract: Solid lipids are non-toxic excipients, which are known to potentially enhance delivery and bioavailability of poorly water-soluble drugs and moreover to mask unpleasant tasting drugs. Multiple unit matrix dosage forms based on solid lipids, such as lipid pellets, can be obtained by solvent-free cold extrusion and spheronization. This method presents advantages in the processing of sensitive substances, such as low process temperatures, the absence of solvents and a drying step. However, the material temperature during the spheronization showed to be critical so far. The process leads to increased material temperatures, causing particle agglomeration and discontinuity of the spheronization. In the present study, extrudates of 0.5mm in diameter containing metformin hydrochloride, and either semisynthetic hard fat (Witocan® 42/44) or different ternary mixtures based on hard fat, glyceryl trimyristate, and glyceryl distearate, were spheronized. By applying common process parameters, particle agglomeration or material stickiness on equipment walls was observed in preliminary experiments after 2-6min, depending on the lipid composition. Therefore, an innovative instrumental setup to control the spheronization process was developed utilizing an infrared light source, which was positioned over the particle bed. The new approach enabled a spheronization process that reached the desired spheronization temperature after 2-3min and neither particle agglomeration nor material adherence occurred even after longer process times. The different formulations, even those based on high amount of solid lipids, were successfully spheronized over 15min, resulting in small diameter lipid pellets with smooth surface and aspect ratios below 1.3.
authors: Heinrich-Heine-University, Institute of Pharmaceutics and Biopharmaceutics, Duesseldorf, Germany.
authors: Gustavo Freire
authors: GF
authors: Petrovick
authors: Heinrich-Heine-University, Institute of Pharmaceutics and Biopharmaceutics, Duesseldorf, Germany.
authors: Miriam
authors: M
authors: Pein
authors: Heinrich-Heine-University, Institute of Pharmaceutics and Biopharmaceutics, Duesseldorf, Germany.
authors: Markus
authors: M
authors: Thommes
authors: Heinrich-Heine-University, Institute of Pharmaceutics and Biopharmaceutics, Duesseldorf, Germany. Electronic address: Joerg.Breitkreutz@hhu.de.
authors: Jörg
authors: J
authors: Breitkreutz
mesh_terms: D002626:Chemistry, Pharmaceutical / Q000379:methods*; D004339:Drug Compounding / Q000379:methods; D016503:Drug Delivery Systems; D005079:Excipients / Q000737:chemistry*; D008055:Lipids / Q000737:chemistry*; D008687:Metformin / Q000008:administration & dosage* / Q000737:chemistry; D012995:Solubility; D012997:Solvents / Q000737:chemistry; D013696:Temperature; D013997:Time Factors
chemical_list: D005079:Excipients; D008055:Lipids; D012997:Solvents; D008687:Metformin
keywords: Lipid pellets; Metformin; Process optimisation; Solid lipid extrusion; Spheronization; Temperature control